Environment-Related Adaptive Changes of Gut Commensal Microbiota Do not Alter Colonic Toll-Like Receptors but Modulate the Local Expression of Sensory-Related Systems in Rats

Microbial Ecology

Volumn 66, Issue 1, 2013, Pages 232-243

  Aguilera, M ^a   Vergara, P ^a,b   Martinez V ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); BACTEROIDES; BACTEROIDES SP.; BIFIDOBACTERIUM; LACTOBACILLUS; RATTUS;

PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR;

ADAPTATION; ANIMAL; BACTERIA; BACTERIAL PHENOMENA AND FUNCTIONS; CECUM; CLASSIFICATION; COLON; ECOSYSTEM; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; SYMBIOSIS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; CECUM; COLON; ECOSYSTEM; GENE EXPRESSION; HUMANS; MALE; MICROBIOTA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PATTERN RECOGNITION; SYMBIOSIS; TOLL-LIKE RECEPTORS;

EID: 84878769570     PISSN: 00953628     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00248-013-0241-0     Document Type: Article

References (40)

1. Aguilera M, Vergara P, Martinez V (2013) Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice. Neurogastroenterology & Motility, in press. doi: 10. 1111/nmo. 12154.
2. Amaral FA, Sachs D, Costa VV, Fagundes CT, Cisalpino D, Cunha TM, Ferreira SH, Cunha FQ, Silva TA, Nicoli JR, Vieira LQ, Souza DG, Teixeira MM (2008) Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A 105: 2193-2197.
3. Blackshaw LA, Brierley SM, Hughes PA (2010) TRP channels: new targets for visceral pain. Gut 59: 126-135.
4. Brusberg M, Arvidsson S, Kang D, Larsson H, Lindstrom E, Martinez V (2009) CB1 receptors mediate the analgesic effects of cannabinoids on colorectal distension-induced visceral pain in rodents. J Neurosci 29: 1554-1564.
5. Bueno L (2008) Protease activated receptor 2: a new target for IBS treatment. Eur Rev Med Pharmacol Sci 12(Suppl 1): 95-102.
6. Camp JG, Kanther M, Semova I, Rawls JF (2009) Patterns and scales in gastrointestinal microbial ecology. Gastroenterology 136: 1989-2002.
7. Campbell JH, Foster CM, Vishnivetskaya T, Campbell AG, Yang ZK, Wymore A, Palumbo AV, Chesler EJ, Podar M (2012) Host genetic and environmental effects on mouse intestinal microbiota. ISME J 6: 2033-2044.
8. Cario E (2008) Therapeutic impact of toll-like receptors on inflammatory bowel diseases: a multiple-edged sword. Inflamm Bowel Dis 14: 411-421.
9. Carvalho FA, Aitken JD, Vijay-Kumar M, Gewirtz AT (2012) Toll-like receptor-gut microbiota interactions: perturb at your own risk! Annu Rev Physiol 74: 177-198.
10. Collins SM, Bercik P (2009) The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136: 2003-2014.
11. Coutts AA, Irving AJ, Mackie K, Pertwee RG, Anavi-Goffer S (2002) Localisation of cannabinoid CB(1) receptor immunoreactivity in the guinea pig and rat myenteric plexus. J Comp Neurol 448: 410-422.
12. Davis MP (2012) Drug management of visceral pain: concepts from basic research. Pain Res Treat 2012: 265605.
13. Dinoto A, Suksomcheep A, Ishizuka S, Kimura H, Hanada S, Kamagata Y, Asano K, Tomita F, Yokota A (2006) Modulation of rat cecal microbiota by administration of raffinose and encapsulated Bifidobacterium breve. Appl Environ Microbiol 72: 784-792.
14. Diop L, Guillou S, Durand H (2008) Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial. Nutr Res 28: 1-5.
15. Eutamene H, Lamine F, Chabo C, Theodorou V, Rochat F, Bergonzelli GE, Corthesy-Theulaz I, Fioramonti J, Bueno L (2007) Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J Nutr 137: 1901-1907.
16. Fan YJ, Chen SJ, Yu YC, Si JM, Liu B (2006) A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial. J Zhejiang Univ Sci B 7: 987-991.
17. Haarman M, Knol J (2006) Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 72: 2359-2365.
18. Harmsen HJ, Raangs GC, He T, Degener JE, Welling GW (2002) Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 68: 2982-2990.
19. Holzer P (2009) Opioid receptors in the gastrointestinal tract. Regul Pept 155: 11-17.
20. Honda K, Takeda K (2009) Regulatory mechanisms of immune responses to intestinal bacteria. Mucosal Immunol 2: 187-196.
21. Izzo AA, Sharkey KA (2010) Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 126: 21-38.
22. Kajander K, Hatakka K, Poussa T, Farkkila M, Korpela R (2005) A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 22: 387-394.
23. Kelly D, Mulder IE (2012) Microbiome and immunological interactions. Nutr Rev 70(Suppl 1): S18-S30.
24. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
25. Looijer-van Langen MA, Dieleman LA (2009) Prebiotics in chronic intestinal inflammation. Inflamm Bowel Dis 15: 454-462.
26. Ma BW, Bokulich NA, Castillo PA, Kananurak A, Underwood MA, Mills DA, Bevins CL (2012) Routine habitat change: a source of unrecognized transient alteration of intestinal microbiota in laboratory mice. PLoS One 7: e47416.
27. Marques R, Boneca IG (2011) Expression and functional importance of innate immune receptors by intestinal epithelial cells. Cell Mol Life Sci 68: 3661-3673.
28. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
29. Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, Ouwehand A, Leyer G, Carcano D, Colombel JF, Ardid D, Desreumaux P (2007) Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 13: 35-37.
30. Selinummi J, Seppala J, Yli-Harja O, Puhakka JA (2005) Software for quantification of labeled bacteria from digital microscope images by automated image analysis. Biotechniques 39: 859-863.
31. Teran-Ventura E, Roca M, Martin MT, Abarca ML, Martinez V, Vergara P (2010) Characterization of housing-related spontaneous variations of gut microbiota and expression of toll-like receptors 2 and 4 in rats. Microb Ecol 60: 691-702.
32. Veerappan GR, Betteridge J, Young PE (2012) Probiotics for the treatment of inflammatory bowel disease. Curr Gastroenterol Rep 14: 324-333.
33. Verdu EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, Mao Y, Wang L, Rochat F, Collins SM (2006) Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55: 182-190.
34. Verdu EF, Collins SM (2005) Irritable bowel syndrome and probiotics: from rationale to clinical use. Curr Opin Gastroenterol 21: 697-701.
35. Whelan K (2011) Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care 14: 581-587.
36. Wildt S, Munck LK, Vinter-Jensen L, Hanse BF, Nordgaard-Lassen I, Christensen S, Avnstroem S, Rasmussen SN, Rumessen JJ (2006) Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis. Inflamm Bowel Dis 12: 395-401.
37. Williams EA, Stimpson J, Wang D, Plummer S, Garaiova I, Barker ME, Corfe BM (2009) Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment Pharmacol Ther 29: 97-103.
38. Wright KL, Duncan M, Sharkey KA (2008) Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol 153: 263-270.
39. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
40. Zwielehner J, Lassl C, Hippe B, Pointner A, Switzeny OJ, Remely M, Kitzweger E, Ruckser R, Haslberger AG (2011) Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS One 6: e28654.